Infecciones por bacilos gramnegativos no fermentadoresPseudomonas aeruginosa, Acinetobacter sp. y Stenotrophomonas maltophilia

  1. Hernández Torres, Alicia
  2. Elisa García Vázquez 1
  3. Herrero Martínez, José Antonio
  4. Gómez Gómez, Joaquín
  1. 1 Universidad de Murcia
    info

    Universidad de Murcia

    Murcia, España

    ROR https://ror.org/03p3aeb86

Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2014

Issue Title: Enfermedades infecciosas (VIII): infecciones por bacilos gramnegativos

Series: 11

Issue: 56

Pages: 3311-3316

Type: Article

DOI: 10.1016/S0304-5412(14)70775-9 DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

Nonfermenting gram-negative bacilli include a series of microorganisms of which the genera Pseudomonas, Acinetobacter and Stenotrophomonas are of greatest clinical relevance in humans. Their fundamental characteristic is that they behave as opportunistic pathogens and, as such, affect susceptible patients through a series of processes, such as undergoing prior antibiotherapy, undergoing various types of instrumentation, undergoing some type of immune suppression (primary and induced) and admission to high-risk units such as intensive care units. In this type of patients, the bacilli will be able to cause a wide assortment of clinical presentations. The major problem in managing these patients comes from the fact that these microorganisms have a considerable capacity for acquiring numerous resistance mechanisms, which increasingly limits the therapeutic options.

Bibliographic References

  • Allen DM, Hartman BJ. Especie Acinetobacter. Enfermedades infecciosas. Principios y práctica. 6ª ed. Barcelona: Elsevier; 2005. p. 2632-6.
  • Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012;25(1):2-41.
  • Cornelis P, Dingemans. Pseudomonas aeruginosa adapts its iron uptake strategies in function of the type of infections. Front Microbiol. 2013;75(3):1-7.
  • Florescu DF, Qiu F, McCartan MA, Mindru C, Fey PD, Kalil AC. Is the efficacy and safety of colistin for the treatment of ventilator associated pneumonia? A systematic review and metaregression. Clin Infect Dis. 2012;54(5):670-80.
  • Gellatly SL, Hancock R. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog Dis. 2013; 67:159-73.
  • Hernández Torres A, García Vázquez E, Yagüe G, Gómez Gómez J. Acinetobacter baumannii multirresistente: situación clínica actual y nuevas perspectivas. Rev Esp Quimioter. 2010;23(1):12-9.
  • Hernández-Torres A, García-Vázquez E, Gómez J, Canteras M, Ruiz J, Fernández-Rufete A. Carbapenem and multidrug resistant Acinetobacter baumannii colonisation/infection: epidemiology and factors associated with infection. Med Clin (Barc). 2010;135(9):389-96.
  • Hernández-Torres A, García-Vázquez E, Gómez J, Canteras M, Ruiz J, Yagüe G. Multidrug and carbapenem resistant Acinetobacter baumannii infections: Factors associated with mortality. Med Clin (Barc). 2012;138(15):650-5.
  • Hu Y, Li L, Li W, Xu H, He P, Yan X. Combination antibiotic therapy versus monotherapy for Pseudomonas aeruginosa bacteraemia: a meta-analysis of retrospective and prospective studies. Int J Antimicrob Agents. 2013;42(6):492-6.
  • Lai C-H, Wong WW, Chin C, Huang CK, Lin HH, Chen WF. Central venous catheter related Stenotrophomonas maltophilia bacteraemia and associated relapsing bacteraemia in haematology and oncology patients. Clin Microbiol Infect. 2006;12:986-91.
  • Majik MS, Parvatkar PT. Next generation biofilm inhibitors for Pseudomonas aeruginosa: synthesis and rational design approaches. Curr Top Med Chem. 2014;14:81-109.
  • Maschmeyer G, Göbel UB. Stenotrophomonas maltophilia y Burkholderia cepacia. Enfermedades infecciosas. Principios y práctica. 6ª ed. Enfermedades infecciosas/Principios y Práctica. Barcelona: Elsevier; 2005. p. 2615-22.
  • Morita Y, Tomida J, Kawamura Y. Responses of Pseudomonas aeruginosa to antimicrobials. Front Microbiol. 4;422:1-8.
  • Nagobaa BS, Selkarb SP, Wadherc BJ, Gandhia RC. Acetic acid treatment of pseudomonal wound infections -A review. J Infect Public Health. 2013;6:410-5.
  • Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3): 538-82.
  • Pier BG, Ramphal R. Pseudomonas aeruginosa. Enfermedades infecciosas. Principios y práctica. 6ª ed. Barcelona: Elsevier; 2005. p. 2587-615.
  • Sánchez A, Gattarello S, Rello J. New treatment options for infections caused by multirresistant strains of Pseudomonas aeruginosa and other nonfermenting gramnegative bacilli. Semin Respir Crit Care Med. 2011;32:151-8.1
Data source: Dialnet